Chemocentryx (CCXI) Posts Q1 Loss of 28c/Share

Chemocentryx (NASDAQ: CCXI) reported Q1 EPS of ($0.28), $0.07 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $1.02 million versus the consensus estimate of $4.75 million.

For earnings history and earnings-related data on Chemocentryx (CCXI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity to acquire Harte Hanks for $5 per share in cash and stock
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat